EUFLEXXA (1% SODIUM HYALURONATE)
FDA premarket approval P010029/S024 · decided 2015-05-07
Approval details
- PMA number
- P010029
- Supplement
- S024
- Supplement type
- 30-Day Notice
- Supplement reason
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
- Trade name
- EUFLEXXA (1% SODIUM HYALURONATE)
- Generic name
- Acid, hyaluronic, intraarticular
- Applicant
- Ferring Pharmaceuticals, Inc.
- Date received
- 2015-04-23
- Decision date
- 2015-05-07
- Days to decision
- 14 days
- Decision code
- OK30
- Product code
- MOZ
- Advisory committee
- Orthopedic
- Expedited review
- No
- Location
- Parsippany, NJ
- Statement
- SCALE UP THE MANUFACTURING PROCESS OF EUFLEXXA BY INCREASING THE FORMULATION CAPACITY.
Class III intelligence, same tools
PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.